RecruitingPhase 1NCT06925542
Rare condition
Diffuse cutaneous systemic sclerosis
17
studies recruiting now
as of 7 Sept 2026
87
studies registered in total
as of 7 Sept 2026
29
countries with a recruiting site
as of 7 Sept 2026
16 Mar 2026
most recent study posted
among recruiting studies
Recruiting trials
RecruitingPhase 1 / Phase 2NCT07473154
Controlling Hyperactive Immunity With Long-lived Lymphocytes
RecruitingPhase 2NCT06470048
A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis
RecruitingPhase 2NCT03630211
Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis
RecruitingPhase 2NCT07287670
EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 17 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Diffuse cutaneous systemic sclerosis study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Diffuse cutaneous systemic sclerosis
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations, and the genes involved (CAV1, HLA-DRB1, CCN2, IRF5, CCR6).
Treatments being studied
18 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Phase 3Lenabasum
Phase 3Sildenafil Citrate (Granpidam)
Phase 2/3Acetylcysteine (A-cys)
Phase 2Ianalumab
Phase 2Abatacept (Orencia)
Phase 2Telitacicept
Phase 2Etrinabdione
Phase 2Dersimelagon
+ 10 more in development
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).